Probing the acting mode and advantages of RMC-4550 as an Src-homology 2 domain-containing protein tyrosine phosphatase (SHP2) inhibitor at molecular level through molecular docking and molecular dynamics

Applied Biochemistry and Biotechnology

(2013) · Applied Biochemistry and Biotechnology · doi:10.1007/12010.1559-0291 · Cited by 1,397 · see citing works

Role of Molecular Dynamics and Related Methods in Drug Discovery

Vivo, M. D., Masetti, M., Bottegoni, G., & Cavalli, A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01684 · Cited by 1,330 · see citing works

Principal Component Analysis: A Method for Determining the Essential Dynamics of Proteins

David, C., & Jacobs, D. J. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-658-0_11 · Cited by 1,255 · see citing works

Crystal Structure of the Tyrosine Phosphatase SHP-2

Hof, P., Pluskey, S., Dhe‐Paganon, S., Eck, M. J., & Shoelson, S. E. (1998) · Cell · doi:10.1016/s0092-8674(00)80938-1 · Cited by 996 · see citing works

RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers

Nichols, R. J., Haderk, F., Stahlhut, C., Schulze, C. J., Hemmati, G., Wildes, D., Tzitzilonis, C., Mordec, K., Marquez, A., Romero, J., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0169-1 · Cited by 415 · see citing works

CHARMM fluctuating charge force field for proteins: II Protein/solvent properties from molecular dynamics simulations using a nonadditive electrostatic model

Patel, S., MacKerell, A. D., & Brooks, C. L. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20077 · Cited by 409 · see citing works

Allosteric inhibition of SHP2: identification of a potent, selective, and orally efficacious phosphatase inhibitor

Garcia Fortanet, J., Chen, C. H.-T., Chen, Y.-N. P., Chen, Z., Deng, Z., Firestone, B., Fekkes, P., Fodor, M., Fortin, P. D., Fridrich, C., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00680 · Cited by 298 · see citing works

Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation

Fragale, A., Tartaglia, M., Wu, J., & Gelb, B. D. (2004) · Human Mutation · doi:10.1002/humu.20005 · Cited by 193 · see citing works

Improved Method for the Identification and Validation of Allosteric Sites

Song, K., Liu, X., Huang, W., Lu, S., Shen, Q., Zhang, L., & Zhang, J. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00014 · Cited by 152 · see citing works

Structural and Mechanistic Insights into LEOPARD Syndrome-Associated SHP2 Mutations

Yu, Z.-H., Xu, J., Walls, C. D., Chen, L., Zhang, S., Zhang, R., Wu, L., Wang, L., Liu, S., & Zhang, Z. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.450023 · Cited by 138 · see citing works

Shp2/MAPK signaling controls goblet/paneth cell fate decisions in the intestine

Heuberger, J., Kosel, F., Qi, J., Grossmann, K. S., Rajewsky, K., & Birchmeier, W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309342111 · Cited by 124 · see citing works

GROMOS96 43a1 performance on the characterization of glycoprotein conformational ensembles through molecular dynamics simulations

Fachin, L. P., Fernandes, C. L., & Verli, H. (2009) · Carbohydrate Research · doi:10.1016/j.carres.2008.12.025 · Cited by 116 · see citing works

Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment

Xie, J., Si, X., Gu, S., Wang, M., Shen, J. H., Li, H., Shen, J. H., Li, D., Fang, Y., Liu, C., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01520 · Cited by 113 · see citing works

Polysaccharide isolated from Phellinus linteus mycelia exerts anti-inflammatory effects via MAPK and PPAR signaling pathways

Hu, T., Lin, Q., Guo, T., Yang, T., Zhou, W., Deng, X., Yan, J., Luo, Y., Ju, M., & Luo, F. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.08.021 · Cited by 113 · see citing works

ASBench: benchmarking sets for allosteric discovery

Huang, W., Wang, G., Shen, Q., Liu, X., Lu, S., Geng, L., Huang, Z., & Zhang, J. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv169 · Cited by 107 · see citing works

Determination of Hydrogen Bond Structure in Water versus Aprotic Environments To Test the Relationship Between Length and Stability

Sigala, P. A., Ruben, E. A., Liu, C. W., Piccoli, P. M. B., Hohenstein, E. G., Martı́nez, T. J., Schultz, A. J., & Herschlag, D. (2015) · Journal of the American Chemical Society · doi:10.1021/ja512980h · Cited by 101 · see citing works

Phosphatase-defective LEOPARD syndrome mutations in PTPN11 gene have gain-of-function effects during Drosophila development

Oishi, K., Zhang, H., Gault, W. J., Wang, C. J., Tan, C. C., Kim, I.-K., Ying, H., Rahman, T., Pica, N., Tartaglia, M., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn336 · Cited by 91 · see citing works

Targeting Protein Tyrosine Phosphatase SHP2 for Therapeutic Intervention

Butterworth, S., Overduin, M., & Barr, A. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.88 · Cited by 78 · see citing works

The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain‐derived neurotrophic factor

Easton, J. B., Royer, A. R., & Middlemas, D. S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03789.x · Cited by 70 · see citing works

SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer

Shujing, Y. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i15.2028 · Cited by 67 · see citing works

A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth

Patel, Y. K., Shah, N. R., Lee, J. S., Markoutsa, E., Jie, C., Liu, S., Botbyl, R., Reisman, D., Xu, P., & Chen, H. (2016) · Oncotarget · doi:10.18632/oncotarget.7577 · Cited by 62 · see citing works

Molecular dynamics simulations of wild type and mutants of human complement receptor 2 complexed with C3d

Wan, H., Hu, J., Tian, X.-H., & Chang, S. (2012) · Physical Chemistry Chemical Physics · doi:10.1039/c2cp41388d · Cited by 59 · see citing works

The impact of Thr91 mutation on c-Src resistance to UM-164: molecular dynamics study revealed a new opportunity for drug design

Ndagi, U., Mhlongo, N. N., & Soliman, M. E. S. (2017) · Molecular BioSystems · doi:10.1039/c6mb00848h · Cited by 58 · see citing works

Structure, Dynamics, and Interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 Examined by Molecular Modeling, Simulation, and Electrostatic Studies

Bhutani, I., Loharch, S., Gupta, P., Madathil, R., & Parkesh, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119771 · Cited by 49 · see citing works

Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2

Chen, C., Cao, M., Zhu, S., Wang, C., Liang, F., Yan, L., & Luo, D. (2015) · Scientific Reports · doi:10.1038/srep17626 · Cited by 47 · see citing works

Differential flap dynamics in l , d -transpeptidase2 from mycobacterium tuberculosis revealed by molecular dynamics

Fakhar, Z., Govender, T., Maguire, G. E. M., Lamichhane, G., Walker, R. C., Kruger, H. G., & Honarparvar, B. (2017) · Molecular BioSystems · doi:10.1039/c7mb00110j · Cited by 41 · see citing works

Structural basis of valmerins as dual inhibitors of GSK3β/CDK5

Li, X., Wang, X., Tian, Z., Zhao, H., Liang, D., Li, W., Qiu, Y., & Lu, S. (2014) · Journal of Molecular Modeling · doi:10.1007/s00894-014-2407-1 · Cited by 34 · see citing works

Protein secondary structure prediction using a small training set (compact model) combined with a Complex-valued neural network approach

Rashid, S., Saraswathi, S., Kloczkowski, A., Sundaram, S., & Koliński, A. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1209-0 · Cited by 31 · see citing works

Combining molecular dynamics simulation and ligand-receptor contacts analysis as a new approach for pharmacophore modeling: beta-secretase 1 and check point kinase 1 as case studies

Hatmal, M. M., Jaber, S., & Taha, M. O. (2016) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-9984-2 · Cited by 30 · see citing works

An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors

Xie, H., Li, Y., Fang, Y., Xie, X., Qiu, K., & Fu, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161126026 · Cited by 27 · see citing works

Underlying mechanisms of cyclic peptide inhibitors interrupting the interaction of CK2α/CK2β: comparative molecular dynamics simulation studies

Zhou, Y., Zhang, N., Chen, W., Zhao, L., & Zhong, R. (2016) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp06276d · Cited by 26 · see citing works

Coupling high-throughput genetics with phylogenetic information reveals an epistatic interaction on the influenza A virus M segment

Wu, N. C., Du, Y., Le, S., Young, A. P., Zhang, T.-H., Wang, Y., Zhou, J., Yoshizawa, J., Dong, L., Li, X., et al. (2016) · BMC Genomics · doi:10.1186/s12864-015-2358-7 · Cited by 24 · see citing works

Computational Study on the Inhibitor Binding Mode and Allosteric Regulation Mechanism in Hepatitis C Virus NS3/4A Protein

Xue, W., Yang, Y., Wang, X., Liu, H., & Yao, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087077 · Cited by 23 · see citing works

Molecular dynamics simulations provide insights into the origin of gleevec’s selectivity toward human tyrosine kinases

Wang, L., Zheng, G., Liu, X., Ni, D., He, X., Cheng, J., & Lu, S. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1496139 · Cited by 23 · see citing works

Identification of tyrosinase inhibitors from traditional Chinese medicines for the management of hyperpigmentation

Tang, H., & Chen, C. Y. (2015) · SpringerPlus · doi:10.1186/s40064-015-0956-0 · Cited by 22 · see citing works

Comparison of dynamics of wildtype and V94M human UDP-galactose 4-epimerase—A computational perspective on severe epimerase-deficiency galactosemia

Timson, D. J., & Lindert, S. (2013) · Gene · doi:10.1016/j.gene.2013.05.027 · Cited by 22 · see citing works

Structural Mechanism behind Distinct Efficiency of Oct4/Sox2 Proteins in Differentially Spaced DNA Complexes

Yesudhas, D., Anwar, M. A., Panneerselvam, S., Durai, P., Shah, M., & Choi, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147240 · Cited by 21 · see citing works

Zinc finger protein binding to DNA: an energy perspective using molecular dynamics simulation and free energy calculations on mutants of both zinc finger domains and their specific DNA bases

Hamed, M. Y., & Arya, G. (2015) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2015.1068224 · Cited by 20 · see citing works

Integration of Evolutionary Features for the Identification of Functionally Important Residues in Major Facilitator Superfamily Transporters

Jeon, J., Yang, J., & Kim, S. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000522 · Cited by 18 · see citing works

Molecular Mechanism Behind the Resistance of the G1202R-Mutated Anaplastic Lymphoma Kinase to the Approved Drug Ceritinib

Chen, C., He, Z., Xie, D., Zheng, L., Zhao, T., Zhang, X., & Cheng, D. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b02040 · Cited by 18 · see citing works

Non-active site mutations disturb the loop dynamics, dimerization, viral budding and egress of VP40 of the Ebola virus

Balmith, M., & Soliman, M. E. S. (2017) · Molecular BioSystems · doi:10.1039/c6mb00803h · Cited by 17 · see citing works

Unraveling the conformational determinants of LARP7 and 7SK small nuclear RNA by theoretical approaches

Xu, L., Kong, R., Zhu, J., Sun, H., & Chang, S. (2016) · Molecular BioSystems · doi:10.1039/c6mb00252h · Cited by 15 · see citing works

Identification of potential CCR5 inhibitors through pharmacophore-based virtual screening, molecular dynamics simulation and binding free energy analysis

Wang, J., Shu, M., Wang, Y., Hu, Y. Q., Wang, Y., Luo, Y., & Lin, Z. (2016) · Molecular BioSystems · doi:10.1039/c6mb00577b · Cited by 15 · see citing works

Exploring the reason for increased activity of SHP2 caused by D61Y mutation through molecular dynamics

Wang, R., Ma, Y., Du, S., Li, W., Sun, Y., Zhou, H., & Wang, R. (2018) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.10.013 · Cited by 14 · see citing works

3D-QSAR Studies of Dihydropyrazole and Dihydropyrrole Derivatives as Inhibitors of Human Mitotic Kinesin Eg5 Based on Molecular Docking

Luo, X., Shu, M., Wang, Y., Liu, J., Yang, W., & Lin, Z. (2012) · Molecules · doi:10.3390/molecules17022015 · Cited by 13 · see citing works

Dynamical Binding of Hydrogen-Bond Surrogate Derived Bak Helices to Antiapoptotic Protein Bcl-xL

Bao, J., Dong, X. Y., Zhang, J. Z. H., & Arora, P. S. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp809810z · Cited by 13 · see citing works

Understanding the interactions of human follicle stimulating hormone with single-walled carbon nanotubes by molecular dynamics simulation and free energy analysis

Mahmoodi, Y., Mehrnejad, F., & Khalifeh, K. (2017) · European Biophysics Journal · doi:10.1007/s00249-017-1228-4 · Cited by 10 · see citing works

Influence of the R823W mutation on the interaction of the ANKS6–ANKS3: insights from molecular dynamics simulation and free energy analysis

Kan, W., Fang, F., Chen, L., Wang, R., & Deng, Q. (2015) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2015.1071281 · Cited by 9 · see citing works

In Silico Investigation of Potential PARP‐1 Inhibitors from Traditional Chinese Medicine

Chen, K., Sun, M.-F., & Chen, C. Y. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/917605 · Cited by 9 · see citing works

Probing the interaction mechanism of small molecule inhibitors with matriptase based on molecular dynamics simulation and free energy calculations

Sun, D., Zheng, Q., & Zhang, H. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1160259 · Cited by 9 · see citing works

Mutational analysis of microbial hydroxycinnamoyl-CoA hydratase-lyase (HCHL) towards enhancement of binding affinity: A computational approach

Kumar, R. P., Sachan, S. G., & Poddar, R. (2017) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2017.08.014 · Cited by 9 · see citing works

E xploration micromechanism of VP35 IID interaction and recognition dsRNA: A molecular dynamics simulation

Zhang, Y., Ding, J., Zhong, H., & Han, J. (2017) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25269 · Cited by 8 · see citing works

Development of massive multilevel molecular dynamics simulation program, platypus (PLATform for dYnamic protein unified simulation), for the elucidation of protein functions

Takano, Y., Nakata, K., Yonezawa, Y., & Nakamura, H. (2016) · Journal of Computational Chemistry · doi:10.1002/jcc.24318 · Cited by 7 · see citing works

A molecular dynamics approach to explore the structural characterization of cataract causing mutation R58H on human γD crystallin

Karunakaran, R., & Srikumar, P. S. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3342-8 · Cited by 6 · see citing works

Comparative Molecular Field Analysis and Molecular Docking Studies on Quinolinone Derivatives Indicate Potential Hepatitis C Virus Inhibitors

Kullappan, M., Ramaiah, S., & Anbarasu, A. (2019) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-019-00867-4 · Cited by 5 · see citing works

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials

Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396 · see citing works

Targeting SHP2 as a promising strategy for cancer immunotherapy

Liu, Q., Qu, J., Zhao, M., Xu, Q., & Sun, Y. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104595 · Cited by 177 · see citing works

Strategies to overcome drug resistance using SHP2 inhibitors

Liu, M., Gao, S., Elhassan, R. M., Hou, X., & Fang, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.037 · Cited by 59 · see citing works

Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug discovery

Elhassan, R. M., Hou, X., & Fang, H. (2021) · Medicinal Research Reviews · doi:10.1002/med.21871 · Cited by 39 · see citing works

New prospectives on treatment opportunities in RASopathies

Gelb, B. D., Yohe, M. E., Wolf, C. M., & Andelfinger, G. (2022) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.32024 · Cited by 39 · see citing works

Discovery of a Novel Series of Imidazopyrazine Derivatives as Potent SHP2 Allosteric Inhibitors

Torrente, E., Fodale, V., Ciammaichella, A., Ferrigno, F., Ontoria, J. M., Ponzi, S., Rossetti, I., Sferrazza, A., Amaudrut, J., Missineo, A., et al. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00454 · Cited by 27 · see citing works

Emerging chemical scaffolds with potential SHP2 phosphatase inhibitory capabilities – A comprehensive review

Tripathi, R. K. P., & Ayyannan, S. R. (2020) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13807 · Cited by 18 · see citing works

Screening and molecular characterization of lethal mutations of human homogentisate 1, 2 dioxigenase

Gupta, P. S. S., Islam, R. N. U., Banerjee, S., Nayek, A., Rana, M. K., & Bandyopadhyay, A. K. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1736158 · Cited by 17 · see citing works

Small‐Molecule Inhibitors of Shp2 Phosphatase as Potential Chemotherapeutic Agents for Glioblastoma: A Minireview

Mitra, R., & Ayyannan, S. R. (2020) · ChemMedChem · doi:10.1002/cmdc.202000706 · Cited by 17 · see citing works

A small molecule inhibitor targeting SHP2 mutations for the lung carcinoma

Nian, Q., Zeng, J., Li, H., Chen, Y., Zhang, Z., Rodrigues‐Lima, F., Zhao, L., Feng, X., & Shi, J. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.01.002 · Cited by 12 · see citing works

Numeric analysis of reversibility of classic movement equations and constructive criteria of estimating quality of molecular dynamic simulations

Torshin, I. Y., Namiot, V. A., Ng, E., & Tumanyan, V. G. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1773927 · Cited by 8 · see citing works

The clinicopathological and prognostic implications of tyrosine phosphatase SHP2 and ankyrin Hook1 gene expression in non- small cell lung cancer patients treated with gemcitabine plus platinum as first-line chemotherapy

Yang, H., He, L., Zhang, Y., Li, Y., Huang, X., Li, Y., Lou, Y., & Wang, L.-R. (2020) · Annals of Palliative Medicine · doi:10.21037/apm-20-430 · Cited by 7 · see citing works

SHP2 participates in decidualization by activating ERK to maintain normal nuclear localization of progesterone receptor

Chen, L., Zhao, W., Li, M., Yang, Y., Tian, C., Zhang, D., Chang, Z., Zhang, Y., Zhao, Z. J., Chen, Y., et al. (2023) · Reproduction · doi:10.1530/rep-22-0367 · Cited by 7 · see citing works

SHP2 Inhibitors Show Anti-Myeloma Activity and Synergize With Bortezomib in the Treatment of Multiple Myeloma

Zhou, P., Xiao, M., Li, W., Sun, X., Bai, Y., Meng, F., Zhu, Z., Yuan, W., & Sun, K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.841308 · Cited by 6 · see citing works

Exploring the mechanism of the potent allosteric inhibitor compound2 on SHP2 WT and SHP2F285S by molecular dynamics study

Zhou, L., Feng, Y., Ma, Y., Zhang, Z., Wu, J., Du, S., Li, W., Lu, X., Ma, Y., & Wang, R. (2020) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2020.107807 · Cited by 5 · see citing works

Effect of Fragment 1 on the Binding of Epigallocatechin Gallate to the PD-L1 Dimer Explored by Molecular Dynamics

Guo, Y., Guo, Y., Guo, Z., Liu, B., & Xu, J. (2023) · Molecules · doi:10.3390/molecules28237881 · Cited by 2 · see citing works

Targeting SHP2 for Cancer Treatment: Advances and Prospects

Song, Y., & Yu, B. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_256-1 · Cited by 1 · see citing works

Virtual screening and binding mechanism of allosteric inhibitors based on SHP2E76A

Yuan, F., Chen, M., Liu, S., Ma, N., Du, J., Liu, H., Guo, Y., & Yang, L. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.141429 · Cited by 1 · see citing works

Biological Evaluation of Aminobenzoic Acid Derivatives against SHP2

孟, 祥. (2021) · Hans Journal of Medicinal Chemistry · doi:10.12677/hjmce.2021.92011

Biological Evaluation of Benzo[c]heterocyclic Compounds against SHP2

冯, 勃. (2020) · Hans Journal of Medicinal Chemistry · doi:10.12677/hjmce.2020.83009

Targeting SHP2 for Cancer Treatment: Advances and Prospects

Song, Y., & Yu, B. (2025) · Springer eBooks · doi:10.1007/978-3-032-00771-1_256

BindingDB Entry 50018215: Discovery of a Novel Series of Imidazopyrazine Derivatives as Potent SHP2 Allosteric Inhibitors.

BindingDB (2024) · UC San Diego · doi:10.7270/q2h999cf

Exploring the mechanism of the potent allosteric inhibitor compound2 on SHP2 WT and SHP2F285S by molecular dynamics study

Zhou, L., Feng, Y., Ma, Y., Zhang, Z., Wu, J., Du, S., Li, W., Lu, X., Ma, Y., & Wang, R. (2020) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2020.107807 · Cited by 5 · see citing works

Abstract 4878: RMC-4550, an allosteric inhibitor of SHP2: Synthesis, structure, and anti-tumor activity

Koltun, E. S., Aay, N., Buckl, A. K., Jogalekar, A. S., Kiss, G., Marquez, A., Mellem, K. T., Mordec, K., Saldajeno-Concar, M., Semko, C. M., et al. (2018) · Cancer Research · doi:10.1158/1538-7445.am2018-4878 · Cited by 18 · see citing works

Potential Competitive Inhibitors of SHP-2 Identified by Structure-Based Virtual Screening and Molecular Dynamics Simulation

Uba, A. İ., & Wu, C. F. (2022) · ACS symposium series · doi:10.1021/bk-2022-1428.ch008 · Cited by 1 · see citing works

Decoding the selective mechanism behind a monobody inhibitor to the phosphatase domain of SHP2: insights from molecular dynamics simulations

Wang, Y., Ji, M., Zhou, L., Zhang, Q., Lu, X., Liu, N., Li, X., & Lu, S. (2025) · Physical Chemistry Chemical Physics · doi:10.1039/d5cp00211g · Cited by 5 · see citing works

Studies on molecular mechanism between SHP2 and pyridine derivatives by 3D-QSAR, molecular docking and MD simulations

Wang, F., Yang, W., Li, Z., & Zhou, B. (2021) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2021.101346 · Cited by 6 · see citing works